PT3965752T - Combinação farmacêutica compreendendo trazodona para o tratamento de dor neuropática - Google Patents

Combinação farmacêutica compreendendo trazodona para o tratamento de dor neuropática

Info

Publication number
PT3965752T
PT3965752T PT207278433T PT20727843T PT3965752T PT 3965752 T PT3965752 T PT 3965752T PT 207278433 T PT207278433 T PT 207278433T PT 20727843 T PT20727843 T PT 20727843T PT 3965752 T PT3965752 T PT 3965752T
Authority
PT
Portugal
Prior art keywords
trazodone
treatment
neuropathic pain
pharmaceutical combination
pharmaceutical
Prior art date
Application number
PT207278433T
Other languages
English (en)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67875917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3965752(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acraf filed Critical Acraf
Publication of PT3965752T publication Critical patent/PT3965752T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT207278433T 2019-05-07 2020-05-06 Combinação farmacêutica compreendendo trazodona para o tratamento de dor neuropática PT3965752T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000006602A IT201900006602A1 (it) 2019-05-07 2019-05-07 Composizione farmaceutica per il trattamento del dolore neuropatico

Publications (1)

Publication Number Publication Date
PT3965752T true PT3965752T (pt) 2023-10-02

Family

ID=67875917

Family Applications (1)

Application Number Title Priority Date Filing Date
PT207278433T PT3965752T (pt) 2019-05-07 2020-05-06 Combinação farmacêutica compreendendo trazodona para o tratamento de dor neuropática

Country Status (26)

Country Link
US (1) US20220211699A1 (pt)
EP (1) EP3965752B1 (pt)
JP (1) JP2022532518A (pt)
KR (1) KR20220006049A (pt)
CN (1) CN113825505A (pt)
AU (1) AU2020267954A1 (pt)
BR (1) BR112021021410A2 (pt)
CA (1) CA3135097A1 (pt)
DK (1) DK3965752T3 (pt)
EA (1) EA202193050A1 (pt)
ES (1) ES2962966T3 (pt)
FI (1) FI3965752T3 (pt)
GE (1) GEP20237524B (pt)
HR (1) HRP20231252T1 (pt)
HU (1) HUE063756T2 (pt)
IL (1) IL287529B (pt)
IT (1) IT201900006602A1 (pt)
LT (1) LT3965752T (pt)
MX (1) MX2021013489A (pt)
PL (1) PL3965752T3 (pt)
PT (1) PT3965752T (pt)
RS (1) RS64783B1 (pt)
SG (1) SG11202110709QA (pt)
SI (1) SI3965752T1 (pt)
UA (1) UA128174C2 (pt)
WO (1) WO2020225740A1 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2537402C (en) 2003-09-12 2009-05-05 Pfizer Inc. Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
WO2006069293A2 (en) * 2004-12-22 2006-06-29 Friedman Robert S Composition comprising n-acetylcysteine and further pain or anti- inflamm medications
US20120083508A1 (en) * 2006-12-22 2012-04-05 Allergan, Inc. Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain
US10300031B2 (en) * 2007-08-06 2019-05-28 Trinity Laboratories Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
KR20130002292A (ko) 2011-06-28 2013-01-07 주식회사 비보존 다중 타겟팅의 상승 효과를 유발하는 유효물질의 조합 및 그 용도
EP3881845A3 (en) * 2015-10-22 2021-09-29 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Combination of trazodone and gabapentin for the treatment of pain

Also Published As

Publication number Publication date
LT3965752T (lt) 2023-11-10
WO2020225740A1 (en) 2020-11-12
CA3135097A1 (en) 2020-11-12
US20220211699A1 (en) 2022-07-07
AU2020267954A1 (en) 2021-10-28
HUE063756T2 (hu) 2024-01-28
BR112021021410A2 (pt) 2021-12-21
IT201900006602A1 (it) 2020-11-07
IL287529B (en) 2022-05-01
IL287529A (en) 2021-12-01
EP3965752A1 (en) 2022-03-16
ES2962966T3 (es) 2024-03-22
GEP20237524B (en) 2023-08-10
EA202193050A1 (ru) 2022-02-10
FI3965752T3 (fi) 2023-10-04
HRP20231252T1 (hr) 2024-02-02
SG11202110709QA (en) 2021-11-29
PL3965752T3 (pl) 2024-01-29
SI3965752T1 (sl) 2023-12-29
RS64783B1 (sr) 2023-11-30
CN113825505A (zh) 2021-12-21
EP3965752B1 (en) 2023-08-30
DK3965752T3 (da) 2023-10-09
JP2022532518A (ja) 2022-07-15
MX2021013489A (es) 2021-12-10
KR20220006049A (ko) 2022-01-14
UA128174C2 (uk) 2024-04-24

Similar Documents

Publication Publication Date Title
IL279260A (en) KDM1A inhibitors for the treatment of diseases
IL276398A (en) Combined treatment for mastocytosis
SG11202104923YA (en) Pharmaceutical combination for treatment of cancer
GB201804514D0 (en) Treatment of pyroptosis
ZA202007055B (en) Compositions for the treatment of skin conditions
ZA202006610B (en) Compositions for the treatment of skin conditions
IL276482A (en) Compounds for pain management
GB201804515D0 (en) Treatment of necroptosis
IL290756A (en) Treatment of azoles
EP3813872A4 (en) COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
HUE062092T2 (hu) Neuropátiás fájdalom kezelésére szolgáló, alacsony koncentrációjú FLT-receptorgátló
EP3972593A4 (en) Inhibitor of mnk for the treatment of neuropathic pain
EP3532045A4 (en) USE OF SENICAPOC FOR THE TREATMENT OF NEUROPATHIC PAIN
EP3338771A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF TRAMADOL-ETORICOXIB CHLORHYDRATE FOR THE TREATMENT OF PAIN
IL276228A (en) Compounds and preparations for the treatment of pain
EP3958754C0 (fr) Dispositif pour le traitement de la maladie hemorroïdaire
IL287529B (en) A pharmaceutical combination that includes trazodone for the treatment of neuropathic pain
GB201907305D0 (en) Treatment of conditions
GB201901130D0 (en) Formulation for the treatment of tendinopathies
GB201814764D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
GB202101161D0 (en) Formulations for the treatment of tendinopathies
EP4037689A4 (en) 18-MC FOR THE TREATMENT OF SUBSTANCE USE DISORDERS
GB201917253D0 (en) Treatment of conditions
GB202001137D0 (en) Formulations for the treatment of tendinopathies
GB201911728D0 (en) Bacterial composistions for the treatment of disease